rs7505
Positions:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_014210.4(EVI2A):c.*469C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.501 in 152,988 control chromosomes in the GnomAD database, including 20,966 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.50 ( 20794 hom., cov: 32)
Exomes 𝑓: 0.54 ( 172 hom. )
Consequence
EVI2A
NM_014210.4 3_prime_UTR
NM_014210.4 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 2.43
Genes affected
EVI2A (HGNC:3499): (ecotropic viral integration site 2A) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
NF1 (HGNC:7765): (neurofibromin 1) This gene product appears to function as a negative regulator of the ras signal transduction pathway. Mutations in this gene have been linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome. The mRNA for this gene is subject to RNA editing (CGA>UGA->Arg1306Term) resulting in premature translation termination. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.615 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EVI2A | NM_014210.4 | c.*469C>T | 3_prime_UTR_variant | 2/2 | ENST00000462804.3 | NP_055025.2 | ||
NF1 | NM_001042492.3 | c.4836-7986G>A | intron_variant | ENST00000358273.9 | NP_001035957.1 | |||
EVI2A | NM_001003927.3 | c.*469C>T | 3_prime_UTR_variant | 3/3 | NP_001003927.1 | |||
NF1 | NM_000267.3 | c.4773-7986G>A | intron_variant | NP_000258.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EVI2A | ENST00000462804 | c.*469C>T | 3_prime_UTR_variant | 2/2 | 1 | NM_014210.4 | ENSP00000420557.3 | |||
NF1 | ENST00000358273.9 | c.4836-7986G>A | intron_variant | 1 | NM_001042492.3 | ENSP00000351015.4 | ||||
ENSG00000265118 | ENST00000578584.5 | c.478+474C>T | intron_variant | 2 | ENSP00000463981.2 |
Frequencies
GnomAD3 genomes AF: 0.501 AC: 76012AN: 151788Hom.: 20786 Cov.: 32
GnomAD3 genomes
AF:
AC:
76012
AN:
151788
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.538 AC: 582AN: 1082Hom.: 172 Cov.: 0 AF XY: 0.534 AC XY: 314AN XY: 588
GnomAD4 exome
AF:
AC:
582
AN:
1082
Hom.:
Cov.:
0
AF XY:
AC XY:
314
AN XY:
588
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.501 AC: 76045AN: 151906Hom.: 20794 Cov.: 32 AF XY: 0.498 AC XY: 36981AN XY: 74242
GnomAD4 genome
AF:
AC:
76045
AN:
151906
Hom.:
Cov.:
32
AF XY:
AC XY:
36981
AN XY:
74242
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at